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Summary statement: 
In this study we evaluated the impact of scan density on spectral domain OCT 
(SDOCT) thickness and volume measurements in patients with Neovascular 
Age-Related Macular Degeneration. In particular, we define the minimum 
scanning density (32 B-scans) required in order to obtain reliable retinal 
thickness and volume maps for different choroidal neovascularization features 
like sub retinal fluid, sub retinal hyper reflective material, pigment epithelial 
detachment.  
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Abstract 
Purpose: To assess the influence of varying B-scan frame sampling densities 
on retinal thickness and volume measurements from spectral domain optical 
coherence tomography (OCT) in eyes with neovascular age-related macular 
degeneration (AMD). 
Methods: Volume OCT data (512x128 macular cube over 6x6 mm) were 
collected from 39 eyes with neovascular AMD. All 128 B-scans in each image 
set were manually segmented, allowing quantification of the neurosensory 
retina, subretinal fluid (SRF), subretinal hyperreflective material (SRHM), and 
pigment epithelium detachment (PED). Thickness maps were generated for less 
dense subsets of scans, ranging from every other (64 B-scans) to every 64th (2 
B-scans). For each less dense subset, foveal central subfield thickness and 
total macular volume (TMV) were compared with values obtained using all 128 
scans (considered the reference). 
Results For each parameter, the mean absolute difference compared to the 
reference increased with reducing B-scan density. However, these differences 
did not reach statistical significance until frame sampling density was reduced to 
every eighth scan (i.e., 16 B-scans spaced 375 µm apart) for neurosensory 
retina and every fourth scan (i.e., 32 B-scans spaced 188 µm apart) for SRF, 
SRHM and PED. For neurosensory retina, the mean (% error) and maximum (% 
error) absolute differences in TMV, were 0.02 mm3 (0.24%) and 0.06 mm3 
(0.79%), respectively. Similarly at a density of 32 B-scans, mean and maximum 
differences for SRF were 0.004 mm3 (3.47%) and 0.02 mm3 (22.22%). The 
mean differences for SRHM and PED were 0.01 mm3 (8.03%) and 0.01 mm3 
(4.04%), respectively. 
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Conclusions: A minimum of 16 equally spaced B-scans, covering a 6 x 6 mm 
area, appears necessary to generate retinal thickness measurements similar to 
those obtained using all 128 B-scans in eyes with CNV. When considering other 
CNV lesion features, a minimum of 16 B-scans for SRF and PED and 32 B-
scans for SRHM, are required to generate volume maps similar to ground truth 
values. These findings may have implications for the design of acquisition and 
grading protocols for clinical trials using OCT in neovascular AMD. 
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Age-related macular degeneration (AMD) is a common cause of visual 
impairment in the United States,1 with its neovascular form a leading cause of 
irreversible blinding in elderly populations.2 Spectral domain optical coherence 
tomography (OCT) is commonly used to visualize and monitor choroidal 
neovascularization (CNV) associated with AMD. This non-invasive, non-
destructive method of obtaining detailed anatomical data in vivo 2, 3 is used to 
evaluate, diagnose, and monitor diseases such as diabetic retinopathy 4, 5 and 
diabetic macular edema, 6, 7 as well as pigment epithelial layer abnormalities 
and CNV.8 The ability of commercial OCT algorithms to automatically segment 
retinal boundaries and generate thickness and volume maps has been very 
important for its use in clinical practice and in clinical research trials.9, 10 
In disorders such as CNV, however, the automatic segmentation 
boundaries generated by OCT systems are often inaccurate,9,11,12 likely due to 
the extensive outer retinal disruption caused by the disease process. In such 
cases, the retinal layer boundaries must be manually corrected to assure 
accurate measurements.13 The Cirrus and Topcon OCT machines primarily 
segment two boundaries as a means of defining retinal thickness: the inner 
limiting membrane (ILM) and the retinal pigment epithelium (RPE). These 
machines do not differentiate subretinal fluid (SRF) from neurosensory retina, 
nor do they separately quantify subretinal hyperreflective material (SRHM) or 
pigment epithelial detachment (PED). The measurements from volume maps 
generated using OCT can also be affected by artifacts,14-17 poor signal,18 
operator errors, and decentration due to poor fixation.19 
Even newer third-party automated algorithms for CNV lesions require 
human input and optimization.11,12 Since manual correction of the scans is 
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exhaustive and time consuming, it is unsuitable for regular clinical practice and 
presents a challenge even in the context of a reading center for clinical trials.20 
Furthermore, many clinicians do not obtain dense volume scans, but less dense 
sets with only 25-50 B-scans per cube, particularly when using acquisition 
protocols that utilize extensive B-scan averaging. We have shown that features 
of exudation in CNV lesions can be missed when using these reduced 
densities.21 
We have also previously demonstrated that accurate retinal thickness 
and volume maps can be generated using only a small subset of B-scans (32 B-
scans) in a volume cube13,20; however, this study included retinal pathologies of 
various origins and not specifically CNV, wherein significant disruption of the 
outer retina leads to more frequent and severe segmentation errors.16,18,22 
Furthermore, the accuracy of volumes of more localized pathologic features, 
such as PED or SRF, may be more severely compromised by lower sampling 
densities. Thus, in the present study, we address these issues by evaluating the 
impact of reduced B-scan frame sampling, specifically in eyes with neovascular 
AMD, and incorporating CNV lesion parameters such as SRF, SRHM, and 
PED.  
  
Materials and Methods 
 
Data collection 
For this retrospective study, we collected OCT data from 39 eyes of 38 patients 
clinically diagnosed with wet AMD who presented consecutively to the Doheny 
Eye Institute Retina Clinics. All data was generated by one of two spectral 
domain OCT instruments available in the clinic: Cirrus 5000 (Carl Zeiss 
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Meditec, Dublin, CA, 24 patients) or Topcon 3DOCT-2000 (Topcon Medical 
Systems, Inc., Oakland NJ, 15 patients). Data collection and analyses were 
approved by the Medical Institutional Review Board of the University of 
California Los Angeles and the research adhered to the tenets set forth in the 
Declaration of Helsinki. Clinical characteristics such as age, gender, best-
corrected visual acuity, and diagnosis were also obtained from the patient 
records. 
Imaging from both spectral domain OCT machines was performed using 
a standardized macular cube protocol consisting of 128 equally spaced, 
horizontally oriented, 6-mm raster B-scans, each composed of 512 A-scans, 
with scanning performed over a 6 mm square centered on the fovea. This is the 
most commonly used protocol in the Doheny Imaging Unit and is the most 
widely accepted acquisition protocol for clinical trials of retinal disease at the 
Doheny Image Reading Center (DIRC). The raw data from the OCT machines 
were collected and imported into previously described and validated spectral 
domain OCT reading center grading software (3D-OCTOR). 20,23 This software 
allowed the grader to manually segment the relevant boundaries and generate 
retinal thickness and volume maps using the common Early Treatment of 
Diabetic Retinopathy Study macular grid.20 
 
Grading procedure 
The OCT scans were analyzed and graded by three experienced, certified 
DIRC graders (S.B.V., M.G.N., R.K.K.). Boundaries drawn in each of the 128 
OCT B-scans included the ILM, outer border of the photoreceptors, borders of 
SRF and SRHM (if present), inner surface of the RPE, and estimated normal 
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position of the RPE layer (in cases of RPE elevation). All boundaries were 
drawn in accordance with the standard OCT grading protocol of DIRC, which 
has been demonstrated to yield highly reproducible grading in previous 
reports.24 After grading, 3D-OCTOR was used to calculate output parameters 
for various morphologic spaces such as the neurosensory retina, SRHM, SRF, 
and PED (Figure 1). 
 
Generating thickness and volume maps 
Maps were generated to evaluate the relationship and differences between 
each B-scan density for foveal central subfield (FCS) thickness and total volume 
measurements of the neurosensory retina, SRHM, SRF, and PED. As in 
previous publications,24 the space extending between the ILM layer and the 
outer surface of the photoreceptor outer segments was defined as the 
neurosensory retina; the hyporeflective space (Figure 1) between the outer 
photoreceptor border and the inner surface of SRHM (if present) or RPE was 
defined as SRF; the hyperreflective space (Figure 1)  between the outer surface 
of the photoreceptors or SRF (if present) and the inner surface of the RPE was 
defined as SRHM; the space between the inner surface of the RPE and the 
estimated original position of the RPE (often recognized by a thin hyper-
reflective line believed to correspond to the Bruch’s membrane-choriocapillaris 
interface) was defined as PED (Figure 1). Inter-grader reproducibility using the 
OCTOR software and this grading protocol has been demonstrated 
previously.24 
  Retinal thickness maps were generated using all 128 B-scans, and then 
with sequentially smaller subsets of evenly spaced scans: 64 B-scans (every 
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other scan, 94 µm apart); 32 B-scans (every 4th B-scan, 188 µm apart); 16 B-
scans (every 8th B-scan, 376 µm apart); 8 B-scans (every 16th B-scan, 752 µm 
apart); and 4 B-scans (every 32nd B-scan, 1504 µm apart). Thickness and 
volume maps were generated not only for the neurosensory retina, but for the 
CNV lesion features (SRF, SRHM and PED) using a simple bilinear 
interpolation for each sampling density, as previously described.13  
 
Statistical methods: 
The thickness and volume measurements obtained using all 128 B-scans were 
considered to be the reference standard or ground truth. The difference (error) 
between the reference standard and analogous values at each reduced frame 
sampling density was then calculated for all retinal and CNV lesion parameters 
(data from only eyes with CNV features were used for analysis). The means of 
the absolute difference values were compared as opposed to a simple mean, 
which could potentially mask or minimize apparent differences. Percentage 
(relative) errors were calculated by dividing the value of the difference between 
the two measurements by the ground truth/reference (i.e. based on all 128 B-
scans) measurements and multiplying by 100. Bland-Altman plots were 
generated to facilitate comparisons between each B-scan sampling density and 
the ground truth reference values. Best-corrected visual acuity was converted 
into logMAR notation for statistical analysis. The relationship between visual 
acuity and the various calculated parameters was also compared to evaluate for 
consistency with previously published findings.  
All data were analyzed using commercially available SPSS 15.0 
statistical software (SPSS, Chicago, IL) and MedCalc (MedCalc Software, ver. 
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11.3.8, Mariakerke, Belgium). A P value of ≤ 0.05 was considered statistically 
significant. One-way ANOVA and Bonferroni correction were used to determine 
significant differences between and within B-scan densities. 
 
Results 
Clinical characteristics 
A total of 39 eyes with CNV from 38 patients with AMD were included in this 
study. Among the 39 eyes, CNV features such as SRF, SRHM and PED were 
present in 26, 29 and 34 eyes, respectively. The mean patient age was 82.7 ± 
6.27 and the mean logMAR visual acuity was 0.84 (Snellen ≈ 20/140) ± 0.72. 
Twenty-five (66%) of the 38 patients included in our analysis were female, and 
23 (59%) of the eyes studied were left eyes. The association between logMAR 
visual acuity and total volumes of each of the CNV parameters was also 
evaluated. A positive correlation was found between LogMAR visual acuity and 
total volumes of SRHM (r = 0.785, P = <0.001), SRF (r = 0.701, P = <0.001), 
and PED (r=0.963, P = <0.001).  Similar correlations were found for desired 
scan densities. A positive correlation was found between LogMAR visual acuity 
and total volumes of SRHM (at 32 B-scans; r = 0.789, P = <0.001), SRF (at 16 
B-scans; r = 0.700, P = <0.001) and PED (at 16 B-scans; r = 0.955, P = 
<0.001). 
 
Neurosensory retina 
Table 1 demonstrates the absolute difference and percentage error of 
neurosensory retinal thickness measurements. Neurosensory retinal FCS 
thickness and total volume measurements were computed from maps 
 12 
generated after manual grading of retinal boundaries. No statistically significant 
difference was observed between FCS thickness and volume measurements 
until the density was reduced to 1/8 B-scans (375 µm apart) (P = 0.02) or less. 
The mean ± SD for absolute error (relative to ground truth value from all 128 B-
scans) of FCS thickness was 1.21 ± 1.05 µm with 64 B-scans, increasing to 
14.28 ± 14.02 µm with 8 B-scans; whereas for total volume, the mean ± SD of 
absolute error increased from 0.01 ± 0.01 mm³ (64 B-scans) to 0.04 ± 0.03 mm³ 
(8 B-scans). The mean ± SD of percentage errors for FCS NRT thickness and 
total volume were 0.49 ± 0.43% and 0.13 ± 0.10% with 64 B-scans, increasing 
to 6.30 ± 6.95% and 0.56 ± 0.5% with 8 B-scans. Comparative graphs with 
mean and max of absolute difference and percentage error for neurosensory 
retina FCS thickness and total volume are shown in Figure 2. Figure 3 shows 
Bland-Altman plots for the mean difference in neurosensory retina FCS 
thicknesses between ground truth and frame sampling densities of 64, 32, 16 
and 8 B-scans. 
 
 
Subretinal fluid 
No statistically significant difference (P = 1.00) was observed between the total 
SRF volume with any of the reduced sampling densities of 64, 32, 16, 8, or 4 B-
scans and total SRF volume measurements obtained with all 128 B-scans. The 
mean ± SD for absolute error (relative to ground truth) of total SRF volume was 
0.002 ± 0.004 mm³ (64 B-scans) and 0.02 ± 0.02 mm³ (8 B-scans). The mean ± 
SD for percentage error was 2.11 ± 6.53% with 64 B-scans, increasing to 25.32 
± 39.57% with 8 B-scans. Table 2 shows the absolute difference and 
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percentage error measurements of SRF volume at the reduced sampling 
densities. Figure 2 shows the comparative graph of absolute difference and 
percentage error of SRF volume for various sampling densities. 
 
Subretinal hyperreflective material 
No statistically significant difference (P = 0.72) was observed between the total 
SRHM volumes with sampling densities of 64, 32,16, 8, or 4 B-scans relative to 
that obtained with all 128 B-scans. The mean ± SD for absolute error (relative to 
ground truth) for total SRHM volume was 0.01 ± 0.01 mm³ (64 B-scans) and 
0.04 ± 0.03 mm³ (8 B-scans). The mean ± SD for percentage error was 5.44 ± 
11.03% with 64 B-scans, increasing to 30.06 ± 32.45% with 8 B-scans. Table 2 
shows the absolute difference and percentage error measurements of SRHM 
volume at the reduced sampling densities. Figure 2 shows the comparative 
graph of absolute difference and percentage error of SRHM volume for various 
sampling densities.  
 
Pigment epithelium detachment 
No statistically significant difference (P = 0.80) was observed between the total 
PED volume measurements with sampling densities of 64, 32, 16, 8, or 4 B-
scans and that of total PED volume obtained with all 128 B-scans. The mean ± 
SD for absolute error (relative to ground truth) of total PED volume was 0.01 ± 
0.01 mm³ (64 B-scans) and 0.04 ± 0.06 mm³ (8 B-scans). The mean ± SD for 
percentage error was 2.99 ± 7.42% with 64 B-scans, increasing to 10.38 ± 
12.06% with 8 B-scans. Table 2 shows the absolute difference and percentage 
error measurements of PED volume at the reduced sampling densities. Figure 2 
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shows the comparative graph of absolute difference and percentage error of 
PED volume for various sampling densities.  
 
Alternate Starting Scan 
Choosing an alternate starting scan did not yield any difference (p > 0.05) in the 
results, suggesting that the observations were quite stable. The percentage 
error for the volume of each feature with the various starting scans is shown in 
Table 3 
 
Discussion 
In this retrospective cross-sectional study, we observed that a reduction in 
frame sample density of a spectral domain OCT volume scan was associated 
with an increase in the error of FCS thickness and volume measurements in 
eyes with neovascular AMD. The error or difference was not statistically 
significant until the scanning density was reduced to every 8th scan (i.e., 16 B-
scans, with an equal spacing of 376 µm seemed to yield measurements similar 
to the ground truth). At a density of every 8th scan, the percentage difference for 
total neurosensory retinal volume was 0.24%. However, a sudden and 
statistically significant rise in the error was observed with lower sampling 
density, with 0.56% error at a density of 8 B-scans (i.e., every 16th B-scan) and 
1.33% error at a density of 4 B-scans (i.e., every 32nd B-scan). The mean 
percentage error in FCS neurosensory retinal thickness was approximately 
2.5%, with a maximum error of approximately 13.6%. In total neurosensory 
retinal volume, the mean and maximum percentage errors were approximately 
0.2% and 0.8%, respectively, at a scanning density of 16 B-scans.  
 15 
There was no statistically significant difference for the total volume 
measurements of retinal subcomponents such as SRF, SRHM and PED at any 
scan density. This may be due to the smaller study sample with these 
parameters and larger standard deviation values at different scan densities. 
Though the mean values were not statistically significant, the absolute 
differences were potentially clinically significant. Although the choice of 
repeatability standard/limit is somewhat arbitrary, if one wants to achieve a 
mean difference of less than 10%, this requires B-scan densities of 16 for SRF, 
32 for SRHM, and 16 for PED. 
We also observed a positive correlation between total volumes of SRHM, 
SRF, PED and LogMAR visual acuity. In other words, more SRHM, SRF, or 
PED was associated with worse vision. We first described this relationship 
between SRHM and visual function in a cohort of neovascular AMD patients 
using time-domain stratus OCT.25 This finding was subsequently replicated in 
the ABC trial26 and CATT studies.27 Although not main focus of the present 
study, it was reassuring to see that this apparent relationship between SRHM 
and vision was replicated.  
The findings from the present study have relevance for clinical trials of 
diseases associated with CNV that incorporate quantitative OCT analyses. 
Given the enhanced correlation with visual function, lesion sub-analysis would 
seem to be of value in these trials. The potential emergence of new 
therapeutics to specifically target or reduce SRHM may further increase the 
importance of delineating these structures. Manual drawing of retinal 
boundaries and/or correction of the segmentation errors in every B-scan is 
needed to ensure the accuracy of measurements in many eyes with CNV; but 
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the amount of effort required for these corrections may often be impractical, 
particularly with spectral domain OCT datasets having 128 (or more) B-scans.13 
Thus, reducing the sampling density for thickness map calculation may make 
reading center manual correction of SDOCT scans feasible and clinically 
relevant.28 Although use of reduced sampling densities was previously 
demonstrated by Sadda et al13 to be of potential value, the previous studies only 
considered neurosensory retinal thickness and did not focus on CNV lesions. 
Here, we were able to define the acceptable B-scan densities for quantifying 
specific sub-components of CNV lesion. However, it is important to note that an 
“acceptable” B-scan density level is somewhat arbitrary and depends on the 
desired level of precision (our threshold was a mean error of < 10%) for a 
particular study or application. 
Our study has some limitations which should be considered when 
assessing our findings. First, it is a retrospective study and from a tertiary care 
academic medical center and may be subject to ascertainment bias in the types 
of CNV lesions included. For example, our cohort only included eyes with FCS 
neurosensory retinal thickness ranging from 132.9 to 733.70 µm; thus, our 
findings may not extrapolate to eyes with more severe disease or with CNV 
lesions much smaller or larger than the ones included in this study.  In addition, 
because of the enormous time required to manually segment multiple 
boundaries on 128 B-scans per case, the number of subjects included in this 
study was relatively small. Thus, although no statistically significant differences 
were observed until the lower densities were reached, the study was not 
powered to identify smaller but potentially still relevant differences at the higher 
densities. Moreover, our study did not assess whether measurements would 
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differ if an even higher density (>128 B-scans over 6 mm) was used (as a new 
ground truth). High scanning density may also be critical for generation of OCT 
projection maps or en face images, which may be useful for certain ancillary 
analyses or for inter visit registration. Finally, qualitative morphologic 
assessment may still require higher density scans, even if only subsets of these 
scans are used for quantification. 
In summary, we observed that 16 equally spaced horizontal B-scans 
over a 6-mm square may be sufficient to adequately represent and generate a 
reliable macular thickness map of the neurosensory retina, after manual grading 
of retinal boundaries and correction of segmentation errors. Similarly for CNV-
associated features such as SRF or PED, a minimum of 16 B-scans (every 8th 
B-scan) are required to generate volume maps which are similar (within 10%) to 
the ground truth values. A minimum of 32 B-scans (every 4th B scan) is required 
to generate similar ground truth volume maps for SRHM. These findings may 
aid in the design of optimal and streamlined spectral domain OCT scanning and 
grading protocols for future clinical trials using OCT in neovascular AMD. 
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Titles and Legends to Figures 
 
Figure 1: [A] Optical coherence tomography B-scan demonstrating subretinal 
hyper reflective material (SRHM – “hyper reflective” space), subretinal fluid 
(SRF – “hypo reflective” space) and pigment epithelial detachment (PED). [B] 
The clinically relevant boundaries -- internal limiting membrane [ILM], outer 
border of photoreceptors, retinal pigment epithelium (RPE), inner and outer 
borders of SRHM and the estimated normal location of the RPE layer are drawn 
using 3D-OCTOR software. [C] 3D-OCTOR then computes the volumes of the 
spaces (retina, SRHM, SRF, and PED) defined by these boundaries. 
 
Figure 2: Effect of reduced B-scan densities on measurements of foveal central 
subfield (FCS) thickness of neurosensory retina (NRT). [A] Mean absolute error 
(µm), [B] Maximum absolute error (µm), [C] Mean percentage error and [D] 
Maximum percentage error; Effect of reduced B-scan densities on total volume 
measurements of neurosensory retina (NRT), subretinal hyper reflective 
material (SRHM), subretinal fluid (SRF) and pigment epithelium detachment 
(PED) - [E] Mean absolute error (mm³), [F] Maximum absolute error (mm³), [G] 
Mean percentage error and [H] Maximum percentage error.
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Figure 3: Bland-Altman plots demonstrating the level of agreement between the 
ground-truth and each reduced sampling density for the foveal central subfield 
(FCS) neurosensory retinal thickness. Central solid line indicates the mean 
absolute difference, and dotted lines indicate the 95% (upper and lower) 
confidence interval limits. [A] At a sampling density that includes every other B-
Scan (64 B-scans with an equal spacing of 94 µm). [B] At a sampling density 
that includes every 4th B-Scan (32 B-scans with an equal spacing of 188 µm). 
[C] At a B-scan sampling density that includes every 8th B-Scan (16 B-scans 
with an equal spacing of 376 µm). [D] At a B-scan sampling density that 
includes every 16th B-Scan (8 B-scans with an equal spacing of 752 µm). 
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Table 1: Mean absolute difference and percentage error of neurosensory retinal tissue, foveal 
central subfield thickness, and total volume in different sampling groups 
                  
Neurosensory Retinal FCS Thickness 
 
Total Neurosensory Retinal Volume 
Scan 
density  
Mean SD Range 
 
Scan 
density  
Mean SD Range 
128 262.46 107.1 132.9 - 733.70 
 
128 7.25 0.86 5.97 - 10.21 
64 262.56 106.9 133.7 - 732.1 
 
64 7.25 0.86 5.98 - 10.23 
32 265.17 119.1 135.3 - 731.1 
 
32 7.18 0.93 5.97 - 10.22 
16 263.33 102.9 147.5 - 727.1 
 
16 7.25 0.85 5.96 - 10.2 
8 268.9 99.4 149.8 - 713.9 
 
8 7.26 0.86 5.97 - 10.2 
4 266.57 96.3 119.3 - 696.9 
 
4 7.25 0.87 5.97 - 10.42 
         
Absolute difference (µm) 
 
Absolute difference (mm³) 
Scan 
density  
Mean SD Range 
 
Scan 
density  
Mean SD Range 
64 1.21 1.05 0 - 4.10 
 
64 0.01 0.01 0 - 0.04 
32 2.69 2.49 0.1 - 10.90 
 
32 0.01 0.01 0 - 0.07 
16 5.97 6.90 0 - 34.50 
 
16 0.02 0.02 0 - 0.06 
8 14.38 14.02 0.1 - 47.60 
 
8 0.04 0.03 0 - 0.14 
4 25.64 27.68 0 - 112.40 
 
4 0.1 0.08 0 - 0.30 
         
Percentage error (%) 
 
Percentage error (%) 
Scan 
density  
Mean SD Range 
 
Scan 
density  
Mean SD Range 
64 0.49 0.43 0 – 1.85 
 
64 0.13 0.1 0 - 0.52 
32 1.11 0.38 0.03 - 4.90 
 
32 0.2 0.21 0 - 0.91 
16 2.46 3.05 0 – 13.62 
 
16 0.24 0.24 0 - 0.79 
8 6.30 6.95 0.05 - 26.14 
 
8 0.56 0.5 0 - 2.3 
4 9.65 10.42 0 - 55.63 
 
4 1.33 1.03 0 - 4.04 
                  
FCS= foveal central subfield, Scan density= number of B-scans, SD = standard deviation 
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Table 2: Absolute difference and percentage error of total volumes of subretinal fluid, subretinal hyperreflective material 
and pigment epithelium detachment in different sampling groups 
              
         
     Total SRF Volume   Total SRHM Volume   Total PED Volume 
              
Absolute difference (mm³) 
 
Absolute difference (mm³) 
 
Absolute difference (mm³) 
Scan 
density  
Mean SD Range 
 
Scan 
density  
Mean SD Range 
 
Scan 
density  
Mean SD Range 
64 0.002 0.004 0 - 0.01 
 
64 0.01 0.01 0 - 0.06 
 
64 0.01 0.01 0 - 0.03 
32 0.004 0.01 0 - 0.02 
 
32 0.01 0.02 0 - 0.09 
 
32 0.01 0.01 0 - 0.05 
16 0.01 0.01 0 - 0.03 
 
16 0.02 0.02 0 - 0.1 
 
16 0.02 0.02 0 - 0.08 
8 0.02 0.02 0 - 0.06 
 
8 0.04 0.03 0 - 0.17 
 
8 0.04 0.06 0 - 0.32 
4 0.05 0.03 0 - 0.12 
 
4 0.07 0.06 0 - 0.19 
 
4 0.10 0.08 0 - 0.30 
              
Percentage error (%) 
 
Percentage error (%) 
 
Percentage error (%) 
Scan 
density  
Mean SD Range 
 
Scan 
density  
Mean SD Range 
 
Scan 
density  
Mean SD Range 
64 2.11 6.53 0 - 28.57 
 
64 5.44 11.03 0 – 50 
 
64 2.99 7.42 0 - 40 
32 3.47 6.20 0 - 22.22 
 
32 8.03 13.12 0 – 50 
 
32 4.04 7.41 0 - 40 
16 10.21 14.48 0 - 66.67 
 
16 15.43 27.20 0 – 100 
 
16 6.92 7.79 0 - 40 
8 25.32 39.57 0 - 200 
 
8 30.06 32.45 0 - 100 
 
8 10.38 12.06 0 - 60 
4 73.84 73.46 0 - 300 
 
4 52.35 60.88 0 - 266 
 
4 87.12 67.93 0 – 331 
                            
SRHM = subretinal hyperreflective material, SRF = subretinal fluid, PED = pigment epithelium detachment,  
Scan density = number of B-scans, SD = standard deviation 
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Table 3 Absolute difference and percentage error for Neuro sensory Retina, subretinal fluid, subretinal hyperreflective material and pigment epithelium 
detachment with various starting scans versus ground truth values 
  
Neuro Sensory Retina 
Thickness (FCS) 
Neuro Sensory Retina 
volume 
SRHM volume            SRF volume PED volume 
Abs % Error Abs % Error Abs % Error Abs % Error Abs % Error 
Scan starting 
with 0 
1.60 ± 1.1        
(0.21 - 3.10) 
1.52 ± 1.18        
(0 - 3.50) 
0.02 ± 0.02          
(0 - 0.04) 
0.14 ± 0.18           
(0 - 0.53) 
0.01 ± 0.01            
(0 - 0.02) 
2.21 ± 3.58      
(0 - 11.12) 
0.01 ± 0.01             
(0 - 0.01) 
0.37 ± 1.10  
(0 - 3.28 ) 
0.01 ± 0.01    
(0 - 0.02) 
2.74  ± 5.31     
(0 - 15.39) 
Scan starting 
with 1 
0.62 ± 0.43    
(0.09 - 1.17) 
1.14 ± 0.82        
(0 - 2.20) 
0.01 ± 0.01                
(0 - 0.03) 
0.18 ± 0.19                 
(0 - 0.53) 
0.01 ± 0.01          
(0 - 0.02) 
4.46 ± 6.09         
(0 - 14.29) 
0.01 ± 0.01          
(0 - 0.01) 
2.23 ± 4.72 
(0 - 13.34) 
0.01 ± 0.01    
(0 - 0.02) 
0.75 ± 1.54     
(0 - 4.17) 
FCS- Foveal central subfield; Abs-Absolute Difference; Abs and % Error were calculated against ground truth (all B-scans) value; SRHM - Sub Retinal 
Hyper reflective Material; SRF- Sub Retinal Fluid; PED- Pigment Epithelium Detachment 
 
